Our industry experts in Australia and New Zealand provide analysi...
Our industry experts in Australia and New Zealand provide analysis, specialist knowledge and essential market data unavailable elsewhere, to build the most accurate understanding of current trends and future prospects.
In 2023, Australians suffered from an extended influenza season, with months where people were prone to sickness. Analgesics had already seen strong growth in the last few years due to widespread illness as a result of COVID-19.However, strong growth…
With the ending of lockdowns, border closures, and other COVID-19-related restrictions over the course of 2022, Australia has begun to see a return to normality in 2023, with Australians settling into their new hybrid routines and lifestyles.…
Australia has been impacted by an extended season of colds and flu in 2023, with many Australians becoming ill. As the lockdowns and COVID-19 restrictions were lifted, people no longer followed social distancing, and fewer Australians have been…
Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…
Rising inflation in 2023 is placing downwards pressure on disposable incomes in Australia, which is having a significant impact on discretionary spending. While there is still robust interest in dietary supplements, such products are expensive, and…